Ignite Creation Date:
2025-12-25 @ 12:56 AM
Ignite Modification Date:
2026-01-01 @ 1:19 PM
Study NCT ID:
NCT02998567
Status:
RECRUITING
Last Update Posted:
2025-08-17
First Post:
2016-11-02
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combination Study of Guadecitabine/ASTX727 and Pembrolizumab
Sponsor:
Royal Marsden NHS Foundation Trust
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-01-26
Start Date Type:
ACTUAL
Primary Completion Date:
2026-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-09
Completion Date Type:
ESTIMATED
First Submit Date:
2016-11-02
First Submit QC Date:
None
Study First Post Date:
2016-12-20
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-12
Last Update Post Date:
2025-08-17
Last Update Post Date Type:
ACTUAL